Skip to content
Abierto

Award notice, total small business set-aside

Long-Acting Antiviral Implant for the Treatment of HCV

PHS-2024-1

National Institutes of Health, National Institutes of Health Niaid. Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).

Awarded

Luna Labs USA LLC

$299,997.00 on the award notice, September 1, 2024, contract 75N93024C00028

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
C3KTPAW1E1Z7
CAGE
94CB8
Vendor location
San Diego, CA
Contract
75N93024C00025, definitive contract
Obligated
$299,659.00
Actions
3 between July 22, 2024 and June 25, 2025
Competition
Full and Open Competition After Exclusion of Sources, 9 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
An Easy-To-Use, LOW-COST Triplex RDT for the Simultaneous Diagnosis of Hbv, Hcv, and Hiv Infection, Compatible with Field Use in Lmics and AT-HOME Use in the US
Match
award number 75N93024C00025 equals the contract number; same awarding office 75N930 (high confidence)
UEI
MX5XL9PAEUB9
CAGE
9JR13
Vendor location
Chicago, IL
Contract
75N93024C00026, definitive contract
Obligated
$299,961.00
Actions
1 between July 22, 2024 and July 22, 2024
Competition
Full and Open Competition After Exclusion of Sources, 9 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
Development of an Ultrasensitive, Rapid and Easy-To Use AT-HOME Molecular Test for Hcv, HBV and Hiv
Match
award number 75N93024C00026 equals the contract number; same awarding office 75N930 (high confidence)
Recipient
Baebies, Inc.
UEI
NZSZBQ9B84T1
CAGE
71VL0
Vendor location
Durham, NC
Contract
75N93024C00027, definitive contract
Obligated
$299,982.00, potential $2,299,958
Actions
1 between July 22, 2024 and July 22, 2024
Competition
Full and Open Competition After Exclusion of Sources, 11 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
A Simple Multiplexed Platform for Self-Administered Hiv and Hepatitis B Testing
Match
award number 75N93024C00027 equals the contract number; same awarding office 75N930 (high confidence)
UEI
M6JVSYRQRYM9
CAGE
8JML8
Vendor location
Charlottesville, VA
Contract
75N93024C00028, definitive contract
Obligated
$299,997.00
Actions
1 between August 28, 2024 and August 28, 2024
Competition
Full and Open Competition After Exclusion of Sources, 3 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
Long-Acting Antiviral Implant for the Treatment of HCV
Match
award number 75N93024C00028 equals the contract number; same awarding office 75N930 (high confidence)
UEI
PQD4VEHVHWD6
CAGE
9GAD2
Vendor location
Cambridge, MA
Contract
75N93024C00047, definitive contract
Obligated
$295,116.00
Actions
3 between July 31, 2024 and June 30, 2025
Competition
Full and Open Competition After Exclusion of Sources, 8 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
High-Dose and Sustained Delivery of HIV-1 Broadly Neutralizing Antibodies Via Subcutaneous Injection of Hydrogel-Based Microparticle Formations
Match
award number 75N93024C00047 equals the contract number; same awarding office 75N930 (high confidence)
UEI
CV8RCUBHN248
CAGE
95LN8
Vendor location
Newton Center, MA
Contract
75N93024C00048, definitive contract
Obligated
$300,000.00
Actions
3 between July 30, 2024 and September 30, 2024
Competition
Full and Open Competition After Exclusion of Sources, 7 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
Vector-Based Delivery of Hiv Broadly Neutralizing Antibodies
Match
award number 75N93024C00048 equals the contract number; same awarding office 75N930 (high confidence)
UEI
EHMTBALCKFE8
CAGE
7RK00
Vendor location
Ames, IA
Contract
75N93024C00050, definitive contract
Obligated
$300,000.00
Actions
3 between July 30, 2024 and May 15, 2025
Competition
Full and Open Competition After Exclusion of Sources, 7 offers received
Set-aside reported
Small Business Set Aside - Total
Described as
Development of a Next-Generation Immunoprevention Platform Against HIV-1
Match
award number 75N93024C00050 equals the contract number; same awarding office 75N930 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. August 1, 2024

    Award notice

    A Simple Multiplexed Platform for Self-Administered HIV and Hepatitis B Testing

    Awarded to BAEBIES, Inc. Durham for $2,299,958. SAM.gov, notice 036f3a29f2f546edbfe491d31f7c77ef

  2. August 1, 2024

    Award notice

    An easy-to-use, low-cost triplex RDT for the simultaneous diagnosis of HBV, HCV, and HIV infection, compatible with field use in LMICs and at-home use in the US

    Awarded to BIG EYE DIAGNOSTICS Inc. San Diego for $299,659. SAM.gov, notice 40a06fdce2444e9fa713fbd81d58b479

  3. August 1, 2024

    Award notice

    Development of an ultrasensitive, rapid and easy-to use at- home molecular test for HCV, HBV and HIV

    Awarded to CUBIT DIAGNOSTICS, Inc. Chicago for $299,961. SAM.gov, notice 52ab193fc84540449fa199808e0149a2

  4. August 2, 2024

    Award notice

    Vector-Based Delivery of HIV Broadly Neutralizing Antibodies

    Awarded to CURE SYSTEMS LLC Newton Center for $2,300,000. SAM.gov, notice 221052d93edd4901a0ab91ee1e0f4c8d

  5. August 2, 2024

    Award notice

    High-Dose and Sustained Delivery of HIV-1 Broadly Neutralizing Antibodies via Subcutaneous Injection of Hydrogel-based Microparticle Formations

    Awarded to ACOUSTICABIO, Inc. Cambridge for $295,116. SAM.gov, notice 6423d7747f4341f5a3832e880cf83bc6

  6. August 2, 2024

    Award notice

    High-Dose and Sustained Delivery of HIV-1 Broadly Neutralizing Antibodies via Subcutaneous Injection of Hydrogel-based Microparticle Formations

    Awarded to ACOUSTICABIO, Inc. Cambridge for $295,116. SAM.gov, notice 7e94c6c182af4af19dffcf939334a8fa

  7. August 2, 2024

    Award notice

    Development of a Next-Generation Immunoprevention Platform Against HIV-1

    Awarded to NEOVAXSYN Inc. Ames for $300,000. SAM.gov, notice dcca23c63ee345fd9c7ac6296625b922

  8. August 2, 2024

    Award notice

    High-Dose and Sustained Delivery of HIV-1 Broadly Neutralizing Antibodies via Subcutaneous Injection of Hydrogel-based Microparticle Formations

    Awarded to ACOUSTICABIO, Inc. Cambridge for $295,116. SAM.gov, notice e6690e12e12b4daea5654979741a9fcf

  9. August 29, 2024

    Award notice

    DRAFT: An easy-to-use, low-cost triplex RDT for the simultaneous diagnosis of HBV, HCV, and HIV infection, compatible with field use in LMICs and at-home use in the US

    Awarded to BIG EYE DIAGNOSTICS Inc. San Diego for $1. SAM.gov, notice 1020669a61534ccda77c86d06055e58a

  10. September 3, 2024

    Award notice

    Awarded to LUNA LABS USA LLC Charlottesville for $299,997. SAM.gov, notice d56569b1c2394da79f36e26c8fc4ddc4

Points of contact